Increasing Use of Companion Diagnostics Drives Global Genomic Biomarkers Industry
The growing use of genomic testing is transforming disease diagnosis and treatment strategies. Healthcare providers and pharmaceutical companies are increasingly using genomic biomarkers to understand disease mechanisms, identify suitable therapies, and evaluate treatment responses. In addition, advancements in next-generation sequencing, polymerase chain reaction technologies, and molecular...
0 Comments 0 Shares 4 Views 0 Reviews